Therorna Secures Over RMB 280 Million in Series A Round to Accelerate circRNA Tech Development
China-based Therorna Inc., a biotech company specializing in cutting-edge circular RNA (circRNA) technology for next-generation...
China-based Therorna Inc., a biotech company specializing in cutting-edge circular RNA (circRNA) technology for next-generation...
Shanghai ShineYo Medical Device Co., Ltd, a company specializing in electrophysiology and peripheral intervention, has...
Germany-based pharmaceutical giant Boehringer Ingelheim’s venture fund (BIVF) and China-based Hong Kong Science & Technology...
Shenzhen-based fourth-generation sequencing company Anxuyuan Biotechnology (shenzhen) Company Limited (AXBio) has reportedly secured close to...
Beijing-based Iomics Biosciences Co., Ltd, a developer of gene sequencing and diagnostic equipment, has reportedly...
Shenzhen-based medical devices and reagents manufacturer Shenzhen Living Water POCT Co., LTd (LWPOCT) has reportedly...
Hangzhou Tongee Medical Technology Co., Ltd, a Chinese device maker specializing in metabolic disease treatments,...
China-based Joincare Pharmaceutical Group Industry Co., Ltd (SHA: 600380) announced plans to issue Global Depository...
Beijing-based MegaRobo Technologies, a company applying robotics and artificial intelligence (AI) in the life sciences...
China-based Contract Research Organization (CRO) WuXi AppTec Co., Ltd (SHA: 603259, HKG: 2359) has disclosed...
Shenzhen-based META Pharmaceuticals Inc., a developer of immuno-metabolism targeted small molecules, has reportedly raised RMB...
Gritgen Therapeutics, a leading gene therapy drug developer based in Suzhou, has announced the successful...
Pregbio, a Shenzhen-based non-invasive prenatal gene detection company, has reportedly raised an undisclosed amount of...
Exegenesis Bio Inc., a leading gene therapy company, has successfully completed a Series B financing...
Asymchem Laboratories (Tianjin) Co., Ltd, a renowned Contract Development and Manufacturing Organization (CDMO) based in...
LanssonPharm, a company dedicated to the development of central nervous system (CNS) drugs, has announced...